Prior to Imperial College London, I was employed at the National Institute for Health and Care Excellence (NICE) within the Scientific Advice Programme. Here, I provided technical advice to pharmaceutical, medtech, cell therapy, gene therapy and diagnostic companies on their clinical development plans and economic evaluations. I have also contributed to and participated in delivering educational seminars and business development for NICE Scientific Advice.
Before joining NICE, I worked in the Zoonotic Disease Department for the Public Health Foundation of India (PHFI)based out of New Delhi. Here, I worked as a Health Economist & Program Consultant conducting a novel economic evaluation for rabies interventions in India in collaboration with the Center for Infectious Disease Modeling and Analysis (CIDMA), Yale University. Prior to this, I worked with the Health Economics Team at the Warwick Clinical Trials Unit on the psychometric properties of patient reported outcomes measures. I have also previously worked for Bupa Health & Wellbeing as a lab technician and regional training facilitator.
I hold an MSc in Public Health (Health Economics) from the London School of Hygiene & Tropical Medicine (LSHTM) and a BSc in Applied Chemistry from Aston University.
In recent times, urbanisation and expansion of human habitats has resulted in intensification of the human-animal-environment interface which has led to an increase in emerging infectious diseases. At the same time, many environmental threats to health also threaten natural resources, including biodiversity and the provision of essential ecosystem services, which may further undermine health and present barriers for sustainable development. Strategic environmental management is thus uniquely placed to deliver co-benefits across these multiple sectors (e.g. human health and biodiversity).